267
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Comparison of the ocular surface changes following the use of two different prostaglandin F2α analogues containing benzalkonium chloride or polyquad in rabbit eyes

, , &
Pages 195-202 | Received 29 May 2014, Accepted 09 Jul 2014, Published online: 29 Sep 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Andreas Katsanos, Ivano Riva, Banu Bozkurt, Gábor Holló, Luciano Quaranta, Francesco Oddone, Murat Irkec, Gordon N. Dutton & Anastasios G. Konstas. (2022) A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension. Expert Opinion on Drug Safety 21:4, pages 525-539.
Read now
Renee Garofalo, Carolina Kunnen, Rekha Rangarajan, Venkiteshwar Manoj & Howard Ketelson. (2021) Relieving the symptoms of dry eye disease: update on lubricating eye drops containing hydroxypropyl-guar. Clinical and Experimental Optometry 104:8, pages 826-834.
Read now
Karen Walsh & Lyndon Jones. (2019) The use of preservatives in dry eye drops. Clinical Ophthalmology 13, pages 1409-1425.
Read now

Articles from other publishers (15)

Raul E. Ruiz-Lozano, Nadim S. Azar, Hazem M. Mousa, Manuel E. Quiroga-Garza, Seitaro Komai, Lorena Wheelock-Gutierrez, Cristian Cartes & Victor L. Perez. (2023) Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy. Frontiers in Toxicology 5.
Crossref
Miriam Kolko, Gus Gazzard, Christophe Baudouin, Sofie Beier, Françoise Brignole-Baudouin, Barbara Cvenkel, Fredrik Fineide, Anne Hedengran, Anton Hommer, Erik Jespersen, Elisabeth M. Messmer, Rachna Murthy, Amy Gallant Sullivan, Andrew J. Tatham, Tor Paaske Utheim, Marijke Vittrup & David A. Sullivan. (2023) Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment. The Ocular Surface 29, pages 456-468.
Crossref
José Alvaro P. Gomes, Dimitri T. Azar, Christophe Baudouin, Etty Bitton, Wei Chen, Farhad Hafezi, Pedram Hamrah, Ruth E. Hogg, Jutta Horwath-Winter, Georgios A. Kontadakis, Jodhbir S. Mehta, Elisabeth M. Messmer, Victor L. Perez, David Zadok & Mark D.P. Willcox. (2023) TFOS Lifestyle: Impact of elective medications and procedures on the ocular surface. The Ocular Surface 29, pages 331-385.
Crossref
Priyanka Agarwal & Ilva D. Rupenthal. (2023) Non-aqueous formulations in topical ocular drug delivery – A paradigm shift?. Advanced Drug Delivery Reviews 198, pages 114867.
Crossref
Penny A. Asbell & Ömür Ö. Uçakhan. 2023. Dry Eye Disease. Dry Eye Disease 69 95 .
Ilva D. Rupenthal & Priyanka Agarwal. 2023.
Fredrik Fineide, Neil Lagali, Muhammed Yasin Adil, Reiko Arita, Miriam Kolko, Jelle Vehof & Tor P. Utheim. (2022) Topical glaucoma medications – Clinical implications for the ocular surface. The Ocular Surface 26, pages 19-49.
Crossref
Josefine C. Freiberg, Anne Hedengran, Steffen Heegaard, Goran Petrovski, Jette Jacobsen, Barbara Cvenkel & Miriam Kolko. (2022) An Evaluation of the Physicochemical Properties of Preservative-Free 0.005% (w/v) Latanoprost Ophthalmic Solutions, and the Impact on In Vitro Human Conjunctival Goblet Cell Survival. Journal of Clinical Medicine 11:11, pages 3137.
Crossref
Omer Ersin Muz, Kenan Dagdelen, Tuncay Pirdal & Mete Guler. (2021) Comparison of BAK-preserved latanoprost and polyquad-preserved travoprost on ocular surface parameters in patients with glaucoma and ocular hypertension. International Ophthalmology 41:11, pages 3825-3835.
Crossref
Anne Hedengran, Xenia Begun, Olivia Müllertz, Zaynab Mouhammad, Rupali Vohra, Jeffrey Bair, Darlene A. Dartt, Barbara Cvenkel, Steffen Heegaard, Goran Petrovski & Miriam Kolko. (2021) Benzalkonium Chloride-Preserved Anti-Glaucomatous Eye Drops and Their Effect on Human Conjunctival Goblet Cells in vitro. Biomedicine Hub 6:2, pages 69-76.
Crossref
Avani Kathuria, Kiumars Shamloo, Vishal Jhanji & Ajay Sharma. (2021) Categorization of Marketed Artificial Tear Formulations Based on Their Ingredients: A Rational Approach for Their Use. Journal of Clinical Medicine 10:6, pages 1289.
Crossref
José Álvaro Pereira Gomes & José Arthur Pinto Milhomens Filho. (2021) Iatrogenic corneal diseases or conditions. Experimental Eye Research 203, pages 108376.
Crossref
José Alvaro P. Gomes, Dimitri T. Azar, Christophe Baudouin, Nathan Efron, Masatoshi Hirayama, Jutta Horwath-Winter, Terry Kim, Jodhbir S. Mehta, Elisabeth M. Messmer, Jay S. Pepose, Virender S. Sangwan, Alan L. Weiner, Steven E. Wilson & James S. Wolffsohn. (2017) TFOS DEWS II iatrogenic report. The Ocular Surface 15:3, pages 511-538.
Crossref
Qian Yang, Yafang Zhang, Xiuping Liu, Nan Wang, Zhenyu Song & Kaili Wu. (2017) A Comparison of the Effects of Benzalkonium Chloride on Ocular Surfaces between C57BL/6 and BALB/c Mice. International Journal of Molecular Sciences 18:3, pages 509.
Crossref
Thirumurthy Velpandian. 2016. Pharmacology of Ocular Therapeutics. Pharmacology of Ocular Therapeutics 419 430 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.